House Dust Mite Allergy Treatment Market to Reach $5.2 Billion, Globally, by 2031 at 13.4% CAGR: Allied Market Research

Increase in prevalence of allergic diseases associated with house dust mites, rise in demand for immunological products, and rise in R&D activities for manufacturing of anti-allergy drugs drive the growth of the global house dust mite allergy treatment market.

PORTLAND, Ore., July 18, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "House Dust Mite Allergy Treatment Market by Treatment (Antihistamine, Immunotherapy, Other), by Type (Prescription based drugs, Over the counter drugs), by Route of administration (Oral medication, Nasal administration), by Distribution channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global house dust mite allergy treatment industry generated $1.5 billion in 2021, and is anticipated to generate $5.2 billion by 2031, witnessing a CAGR of 13.4% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/16943

Prime determinants of growth

Increase in prevalence of allergic diseases associated with house dust mites, rise in demand for immunological products, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments, and rise in R&D activities for manufacturing of anti-allergy drugs drive the growth of the global house dust mite allergy treatment market. Moreover, increase in initiatives to spreading knowledge regarding different types of allergies presents new opportunities in the coming years.

Covid-19 Scenario

• The outbreak of the Covid-19 pandemic has had a positive impact on the global house dust mite allergy treatment market, owing to implementation of the global lockdown.
• People were forced to stay at home for longer time, which increased the exposure to indoor pollutant. This in turn, boosted the demand for house dust mite allergy treatment.

Scope of the Report: -

The prescription-based drugs segment to maintain its leadership status throughout the forecast period

Based on type, the prescription-based drugs segment held the highest market share in 2021, accounting for nearly three-fifths of the global house dust mite allergy treatment market, and is estimated to maintain its leadership status throughout the forecast period, owing to increase in prevalence of house dust mite allergy diseases and initiatives taken by government & private organization to spread awareness about allergic diseases. However, the over-the-counter drugs segment is projected to manifest the highest CAGR of 13.6% from 2022 to 2031, owing to increase in demand for over-the-counter drugs and increase in number of approvals for over-the-counter anti-allergic drugs.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/17353?reqfor=covid

The hospital pharmacy segment to maintain its lead position during the forecast period

Based on distribution channel, the hospital pharmacy segment accounted for the largest share in 2021, contributing to nearly half of the global house dust mite allergy treatment market, and is projected to maintain its lead position during the forecast period. Moreover, the same segment is expected to portray the largest CAGR of 13.9% from 2022 to 2031, owing to rise in prevalence of allergic diseases, surge in demand for monoclonal antibodies, and initiatives taken by government for advancement of hospital pharmacies.

Europe to maintain its dominance by 2031

Based on region, Europe held the highest market share in terms of revenue 2021, accounting for more than two-fifths of the global house dust mite allergy treatment market, owing to rise in prevalence of asthma & allergic rhinitis, increase in number of in-house dust pollution, presence of key players, and development in increase in R&D activities in the pharmaceutical sector in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 14.4% from 2022 to 203, owing to increase in prevalence of house dust mite allergy diseases, rise in awareness about spreading knowledge regarding allergens, surge in healthcare expenditure, and rise in adoption of immunotherapy drugs for the treatment of house dust mite allergies. 

Leading Market Players: -

• ALK Abello A S
• Allergy Therapeutics PLC
• Bayer AG
• Catalent Pharma Solutions Limited
• GlaxoSmithKline plc.
• johnson and johnson md&d
• Merz Pharma GmbH an Co. KGaA
• Sanofi
• Seqirus UK Limited
• Shionogi and Co. Ltd.

Key Benefits for Stakeholders: -

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the house dust mite allergy treatment market analysis from 2021 to 2031 to identify the prevailing house dust mite allergy treatment market opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the house dust mite allergy treatment market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global house dust mite allergy treatment market trends, key players, market segments, application areas, and market growth strategies.

 Key Market Segments

• Treatment
• Antihistamine
• Immunotherapy
• Other
• Type
• Prescription based drugs
• Over the counter drugs
• Route of administration
• Oral medication
• Nasal administration
• Distribution channel
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• By Region
• North America
• U.S. House Dust Mite Allergy Treatment Market
• Canada House Dust Mite Allergy Treatment Market
• Mexico House Dust Mite Allergy Treatment Market
• Europe
• Germany House Dust Mite Allergy Treatment Market
• France House Dust Mite Allergy Treatment Market
• U.K. House Dust Mite Allergy Treatment Market
• Italy House Dust Mite Allergy Treatment Market
• Spain House Dust Mite Allergy Treatment Market
• Rest of Europe
• Asia-Pacific
• China House Dust Mite Allergy Treatment Market
• Japan House Dust Mite Allergy Treatment Market
• India House Dust Mite Allergy Treatment Market
• Australia House Dust Mite Allergy Treatment Market
• South Korea House Dust Mite Allergy Treatment Market
• Rest of Asia-Pacific
• LAMEA
• Brazil House Dust Mite Allergy Treatment Market
• Saudi Arabia House Dust Mite Allergy Treatment Market
• South Africa House Dust Mite Allergy Treatment Market
• Rest of LAMEA

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

Bioinformatics Market size generated $8,614.29 million in 2019, and is projected to reach $24,731.61 million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

Oncology Drugs Market size was valued at $135,494.17 million in 2020, and is projected to reach $274,400.63 million by 2030, registering a CAGR of 7.5% from 2021 to 2030.

HIV Drugs Market size was valued at $30,891.48 million in 2019, and is expected to reach $36,495.47 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

In Vitro Fertilization (IVF) Market size in U.S. was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027.

Menstrual Cup Market size accounted for around $632 million in 2018 and is expected to reach $963 million by 2026, registering a CAGR of 5.3% from 2019 to 2026.

Orthodontics Market size was valued at $2,767.4 million in 2020, and is projected to reach $7,637.8 million by 2030, registering a CAGR of 10.7% from 2021 to 2030.

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg